Ondine Biomedical Inc (LON:OBI)
14.75p
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Clinical trial results are weeks away; the outcome determines whether this company survives or soars.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Ondine Biomedical Inc
Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that elimi…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £75.3M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Ondine Biomedical Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free